サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1785892

ブルセラ病ワクチンの世界市場

Brucellosis Vaccines

出版日
ページ情報
英文 276 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
ブルセラ病ワクチンの世界市場
出版日: 2025年08月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 276 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ブルセラ病ワクチンの世界市場は2030年までに3億600万米ドルに達する見込み

2024年に2億4,930万米ドルと推定されるブルセラ病ワクチンの世界市場は、2024～2030年の分析期間にCAGR 3.5%で成長し、2030年には3億600万米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるRB51ワクチンは、CAGR 4.0%を記録し、分析期間終了時には1億6,200万米ドルに達すると予測されます。S19ワクチン分野の成長率は、分析期間中CAGR 3.3%と推定されます。

米国市場は6,790万米ドルと推定、中国はCAGR6.6%で成長予測

米国のブルセラ病ワクチン市場は、2024年には6,790万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに6,130万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは6.6%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.3％と2.7％と予測されています。欧州では、ドイツがCAGR 2.0%で成長すると予測されています。

世界のブルセラ病ワクチン市場- 主要動向と促進要因のまとめ

ブルセラ病ワクチンとは何か、なぜ獣医学およびヒトの健康において重要なのか？

ブルセラ病ワクチンは、家畜や場合によっては人間に影響を及ぼすブルセラ感染を予防する上で非常に重要です。ブルセラ菌によって引き起こされるブルセラ病は、非常に感染力の強い人獣共通感染症であり、家畜の繁殖不全や、発熱、関節痛、疲労などの深刻な健康合併症を引き起こします。この病気はウシ、ヒツジ、ヤギ、ブタで最も流行し、直接の接触、汚染された飼料、未殺菌の乳製品を介して感染します。ワクチン接種は依然として最も効果的な予防手段であり、畜産業の経済的損失を減らし、ヒトへの感染リスクを最小限に抑えます。最も一般的に使用されているワクチンには、S19、RB51（ウシ用）、Rev-1（ヒツジおよびヤギ用）などがあり、いずれも大規模なブルセラ症の蔓延抑制に役立っています。最近の遺伝子組換えワクチン、DNAワクチン、ベクターベースのワクチンの進歩により、免疫原性、安全性、予防効果がさらに向上しています。

ブルセラ病ワクチンの情勢を変える新技術とは？

バイオテクノロジーと免疫学の進歩に伴い、ブルセラ病ワクチンの開発は著しく進化しています。S19やRB51のような従来の弱毒化生ワクチンは、有効ではあるもの、病原性が残存するリスクがあり、バイオセーフティ上の懸念から、場合によっては接種が制限されることもあります。現代のワクチン戦略は、病原性のリスクを低減しながら免疫原性を保持する遺伝子組み換えワクチンに焦点を当てています。また、生きた細菌を導入することなく、特定の細菌抗原を用いて免疫を誘発するサブユニットワクチンの技術革新も、調査によって推進されています。さらに、ナノアジュバントやリポソーム送達システムは、ワクチンの有効性と安定性を高め、家畜の免疫反応を改善しています。ヒト、動物、環境の健康戦略を統合するワンヘルス構想の台頭は、流行地域における監視の強化とワクチンの採用につながりました。世界動物衛生機関（WOAH）や国連食糧農業機関（FAO）などの政府・組織は、この病気を世界的に根絶するため、集団ワクチン接種プログラムの実施、血清学的モニタリング、獣医学インフラの改善に取り組んでいます。

ブルセラ病ワクチン市場の成長はいくつかの要因に牽引されている...

主な成長促進要因としては、家畜頭数の増加、人獣共通感染症に対する意識の高まり、疾病管理に関する政府の厳しい規制などが挙げられます。動物用生物製剤への投資の増加や新規ワクチン製剤の研究開発が市場拡大にさらに拍車をかけています。安全な畜産物に対する世界の需要と酪農の安全規制が、ワクチン採用の増加をもたらしています。さらに、気候変動と世界の貿易の拡大がブルセラ症の蔓延に影響を及ぼしており、各国は予防ワクチン接種戦略の実施を促しています。動物病院、診断研究所、家畜管理プログラムの拡大も市場を強化しています。アジア太平洋やアフリカなど、ブルセラ症が依然として流行している地域では、政府が支援するワクチン接種イニシアチブが先進的なワクチンの需要を加速させており、業界は大きく成長する態勢を整えています。

セグメント

タイプ（RB51ワクチン, S19ワクチン, B19ワクチン,その他のタイプ）;用途（牛用,羊用,山羊用）

調査対象企業の例

  • Anicon Labor GmbH
  • Biogenesis Bago
  • Bioveta a.s.
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Colorado Serum Company
  • CZ Vaccines
  • Fivet Animal Health
  • Hester Biosciences Limited
  • Indian Immunologicals Ltd.
  • Jordan Bio-Industries Center（JOVAC）
  • Laboratorios Tornel
  • Merck & Co., Inc.
  • MSD Animal Health
  • Phibro Animal Health Corporation
  • Vaxxinova
  • VETAL Animal Health Products Inc.
  • Veterinary Technologies Corporation
  • Virbac
  • Zoetis Inc.

AIインテグレーション

私たちは、検証された専門家のコンテンツとAIツールによって、市場と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP29720

Global Brucellosis Vaccines Market to Reach US$306.0 Million by 2030

The global market for Brucellosis Vaccines estimated at US$249.3 Million in the year 2024, is expected to reach US$306.0 Million by 2030, growing at a CAGR of 3.5% over the analysis period 2024-2030. RB51 Vaccine, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$162.0 Million by the end of the analysis period. Growth in the S19 Vaccine segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$67.9 Million While China is Forecast to Grow at 6.6% CAGR

The Brucellosis Vaccines market in the U.S. is estimated at US$67.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$61.3 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Brucellosis Vaccines Market - Key Trends & Drivers Summarized

What Are Brucellosis Vaccines and Why Are They Critical in Veterinary and Human Health?

Brucellosis vaccines are crucial in preventing Brucella infections, which affect livestock and, in some cases, humans. Brucellosis, caused by Brucella bacteria, is a highly contagious zoonotic disease that leads to reproductive failures in animals and severe health complications in humans, including fever, joint pain, and fatigue. The disease is most prevalent in cattle, sheep, goats, and pigs, with transmission occurring through direct contact, contaminated feed, or unpasteurized dairy products. Vaccination remains the most effective preventive measure, reducing economic losses in the livestock industry and minimizing the risk of human infection. The most commonly used vaccines include S19, RB51 (for cattle), and Rev-1 (for sheep and goats), all of which help in controlling the spread of brucellosis at a large scale. Recent advancements in recombinant vaccines, DNA vaccines, and vector-based vaccines have further enhanced immunogenicity, safety, and longevity of protection.

How Are Emerging Technologies Transforming the Brucellosis Vaccine Landscape?

With advancements in biotechnology and immunology, brucellosis vaccine development has evolved significantly. Traditional live-attenuated vaccines like S19 and RB51, though effective, carry risks of residual virulence and are restricted in certain cases due to biosafety concerns. Modern vaccine strategies now focus on genetically modified vaccines that retain immunogenicity while reducing risks of pathogenicity. Research is also driving innovation in subunit vaccines, which use specific bacterial antigens to trigger immunity without introducing live bacteria. Furthermore, nano-adjuvants and liposomal delivery systems are enhancing vaccine efficacy and stability, improving immune response in livestock. The rise of One Health initiatives-which integrate human, animal, and environmental health strategies-has led to increased surveillance and adoption of vaccines in endemic regions. Governments and organizations such as the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) are working to implement mass vaccination programs, serological monitoring, and improved veterinary infrastructure to eradicate the disease globally.

The Growth in the Brucellosis Vaccines Market Is Driven by Several Factors…

Key growth drivers include rising livestock population, increasing awareness about zoonotic diseases, and stringent government regulations on disease control. Growing investments in veterinary biologics and R&D for novel vaccine formulations have further fueled market expansion. The global demand for safe livestock products and dairy safety regulations has led to an uptick in vaccine adoption. Additionally, climate change and global trade expansion are influencing the spread of brucellosis, prompting nations to implement preventive vaccination strategies. The expansion of veterinary clinics, diagnostic laboratories, and livestock management programs is also bolstering the market. In regions such as Asia-Pacific and Africa, where brucellosis remains endemic, government-backed vaccination initiatives are accelerating the demand for advanced vaccines, making the industry poised for significant growth.

SCOPE OF STUDY:

The report analyzes the Brucellosis Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (RB51 Vaccine, S19 Vaccine, B19 Vaccine, Other Types); Application (Cattle Application, Sheep Application, Goat Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Anicon Labor GmbH
  • Biogenesis Bago
  • Bioveta a.s.
  • Boehringer Ingelheim
  • Ceva Sante Animale
  • Colorado Serum Company
  • CZ Vaccines
  • Fivet Animal Health
  • Hester Biosciences Limited
  • Indian Immunologicals Ltd.
  • Jordan Bio-Industries Center (JOVAC)
  • Laboratorios Tornel
  • Merck & Co., Inc.
  • MSD Animal Health
  • Phibro Animal Health Corporation
  • Vaxxinova
  • VETAL Animal Health Products Inc.
  • Veterinary Technologies Corporation
  • Virbac
  • Zoetis Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Brucellosis Vaccines - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Brucellosis in Livestock Drives Global Demand for Effective Vaccination Programs
    • Government-Led Eradication Campaigns and Mandatory Vaccination Policies Propel Market Growth
    • Increased Zoonotic Transmission Risk of Brucellosis to Humans Strengthens Public Health Focus on Animal Vaccines
    • Expansion of Commercial Dairy and Livestock Farming Fuels Adoption of Preventive Veterinary Vaccines
    • Technological Advancements in Live Attenuated and Inactivated Vaccine Development Enhance Efficacy and Safety
    • Growing Research into Novel Subunit and DNA-Based Brucellosis Vaccines Expands Future Market Potential
    • Strategic Support from Global Animal Health Organizations (OIE, FAO, WHO) Encourages Vaccination Initiatives
    • Increasing Public and Private Investment in Animal Health Infrastructure Strengthens Distribution and Access
    • Expansion of Brucellosis Surveillance Programs Enhances Disease Detection and Vaccine Coverage
    • Rising Demand for Multi-Valent and Cross-Protective Vaccines Boosts Innovation in Combination Vaccine Solutions
    • Challenges in Cold Chain Management and Vaccine Delivery in Remote Areas Drive Interest in Thermo-Stable Vaccines
    • High Economic Losses from Brucellosis Outbreaks in Livestock Drive ROI-Backed Adoption of Vaccination Programs
    • Regulatory Approvals and Harmonization of Animal Vaccine Guidelines Influence Product Commercialization
    • Emerging Research on Human Brucellosis Vaccines Opens Long-Term Opportunities in Zoonotic Disease Control
    • Regional Livestock Population Growth, Particularly in Asia-Pacific and Africa, Expands Market for Preventive Vaccines
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Brucellosis Vaccines Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Brucellosis Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Brucellosis Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Brucellosis Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for RB51 Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for RB51 Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for RB51 Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for S19 Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for S19 Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for S19 Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for B19 Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for B19 Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for B19 Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cattle Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cattle Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Cattle Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Sheep Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Sheep Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Sheep Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Goat Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Goat Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Goat Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • JAPAN
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • CHINA
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • EUROPE
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Brucellosis Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Brucellosis Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Brucellosis Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • FRANCE
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • GERMANY
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Brucellosis Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Brucellosis Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Brucellosis Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • INDIA
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Brucellosis Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Brucellosis Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Brucellosis Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Brucellosis Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Brucellosis Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Brucellosis Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030
  • AFRICA
    • Brucellosis Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Brucellosis Vaccines by Type - RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Brucellosis Vaccines by Type - Percentage Breakdown of Value Sales for RB51 Vaccine, S19 Vaccine, B19 Vaccine and Other Types for the Years 2015, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Brucellosis Vaccines by Application - Cattle Application, Sheep Application and Goat Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Brucellosis Vaccines by Application - Percentage Breakdown of Value Sales for Cattle Application, Sheep Application and Goat Application for the Years 2015, 2025 & 2030

IV. COMPETITION